SEC Form 5 · accession 0001354488-15-000654
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tony Liu
Officer — Chief Financial Officer · Director
Period of report
Jan 3, 2014
Accepted (ET)
Feb 13, 2015 · 2:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $5.00 | Jan 3, 2014 | A | 255,000 | A | — | Jan 3, 2024 | Common Stock | 255,000 | 260,300 | D |
Explanation of responses
- F1This option vests according to the following schedule: 1/36th per month following the vesting commencement date of January 3, 2014.